These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 17190529)

  • 1. Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice.
    Post RM; Ketter TA; Uhde T; Ballenger JC
    CNS Drugs; 2007; 21(1):47-71. PubMed ID: 17190529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The place of anticonvulsant therapy in bipolar illness.
    Post RM; Ketter TA; Denicoff K; Pazzaglia PJ; Leverich GS; Marangell LB; Callahan AM; George MS; Frye MA
    Psychopharmacology (Berl); 1996 Nov; 128(2):115-29. PubMed ID: 8956373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.
    Chengappa KN; Gershon S; Levine J
    Bipolar Disord; 2001 Oct; 3(5):215-32. PubMed ID: 11912568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The place of anticonvulsants and other putative mood stabilisers in the treatment of bipolar disorder.
    Mitchell PB
    Aust N Z J Psychiatry; 1999 Dec; 33 Suppl():S99-107. PubMed ID: 10622184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
    Dunner DL
    J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of mood stabilisers in the treatment of the depressive facet of bipolar disorders.
    Bourin M; Prica C
    Neurosci Biobehav Rev; 2007; 31(6):963-75. PubMed ID: 17462734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical correlates of therapeutic response in bipolar disorder.
    Bowden CL
    J Affect Disord; 2001 Dec; 67(1-3):257-65. PubMed ID: 11869775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reassessing carbamazepine in the treatment of bipolar disorder: clinical implications of new data.
    Akiskal HS; Fuller MA; Hirschfeld RM; Keck PE; Ketter TA; Weisler RH
    CNS Spectr; 2005 Jun; 10(6):suppl 1-11; discuss 12-3; quiz 14-5. PubMed ID: 16041864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
    Kowatch RA; Suppes T; Carmody TJ; Bucci JP; Hume JH; Kromelis M; Emslie GJ; Weinberg WA; Rush AJ
    J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):713-20. PubMed ID: 10846305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay.
    Frye MA; Altshuler LL; Szuba MP; Finch NN; Mintz J
    J Clin Psychiatry; 1996 Jan; 57(1):17-21. PubMed ID: 8543542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis.
    Liu HY; Potter MP; Woodworth KY; Yorks DM; Petty CR; Wozniak JR; Faraone SV; Biederman J
    J Am Acad Child Adolesc Psychiatry; 2011 Aug; 50(8):749-62.e39. PubMed ID: 21784295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study.
    Kleindienst N; Greil W
    Neuropsychobiology; 2000; 42 Suppl 1():2-10. PubMed ID: 11093063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder.
    Greil W; Kleindienst N
    Int Clin Psychopharmacol; 1999 Sep; 14(5):277-81. PubMed ID: 10529070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of the daily prospective National Institute of Mental Health Life-Chart Method (NIMH-LCM-p) ratings in clinical trials of bipolar disorder.
    Denicoff KD; Ali SO; Sollinger AB; Smith-Jackson EE; Leverich GS; Post RM
    Depress Anxiety; 2002; 15(1):1-9. PubMed ID: 11816046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Historical review of carbamazepine for the treatment of bipolar disorder.
    Stoner SC; Nelson LA; Lea JW; Marken PA; Sommi RW; Dahmen MM
    Pharmacotherapy; 2007 Jan; 27(1):68-88. PubMed ID: 17192163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
    Nasrallah HA; Ketter TA; Kalali AH
    J Affect Disord; 2006 Oct; 95(1-3):69-78. PubMed ID: 16780960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-release carbamazepine for acute bipolar mania: a review.
    Owen RT
    Drugs Today (Barc); 2006 May; 42(5):283-9. PubMed ID: 16801991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.